SQI Diagnostics, Predictive Health Diagnostics PULS Cardiac Test

SQI Diagnostics and Predictive Health Diagnostics have announced the validation, commercial transition, and installation of SQI's sqidlite system to run Predictive Health's PULS Cardiac Test. The PULS multi-biomarker assay integrates quantification of the body's immune system response to endothelial damage to identify subclinical residual cardiac risk and predict a five year risk of heart attack. The sqidlite system and test kits will be available to Predictive Health's global customer base for purchase to run the PULS Cardiac test in their own laboratories.